Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
American Airlines reported adjusted diluted EPS of $0.16 for the fourth quarter of 2025, missing multiple analyst forecasts and seeing revenue and unit metrics pressured by a government shutdown that the company said reduced top-line revenue by $325 million. While premium product revenue outperformed main cabin results and management provided upbea…
Bernstein SocGen lowered its 12-month price target for UnitedHealth Group (UNH) to $405 from $444 but left its Outperform recommendation unchanged. The analyst house made modest cuts to EPS forecasts across the mid-to-late decade and flagged investor worries about the long-term Medicare Advantage funding outlook as the driver of a roughly 9% target…
Wolfe Research maintained an Outperform rating on ASML with a EUR1,400 price target after the company reported fourth-quarter results above expectations and issued first-quarter guidance well ahead of consensus. ASML also lifted its calendar year 2026 revenue midpoint to €36.5 billion, an increase of 12% from prior guidance and above consensus of €…
Bernstein SocGen Group maintained an Outperform rating and a $298.00 price target on Boeing following the company’s fourth-quarter results. The target implies about 22% upside from the prevailing share price of $244.56, though InvestingPro’s Fair Value model flags the stock as potentially overvalued. The quarter featured materially stronger-than-ex…
Bernstein SocGen Group raised its price objective on PACCAR to $138 from $125 while keeping an Outperform rating, even after the truck maker reported results and guidance that matched market expectations but flagged parts and operations margins roughly 75 basis points below consensus. The firm highlighted a reset in investor expectations and said c…
Bernstein SocGen Group reiterated an Outperform rating on Accor SA and lifted its price target to EUR56.60 from EUR52.40, pointing to expected RevPAR strength in 2026, improved U.S. conditions, faster EBITDA growth versus IHG, and stronger cash-return metrics. InvestingPro data shows Accor trading below Fair Value with a Financial Health score of "…
Bernstein SocGen Group maintained its Market Perform rating on HCA Healthcare with a $503 price target, roughly in line with the stock's trading level and close to its 52-week high. The firm highlighted stronger-than-expected margins driving EBITDA growth, supported by rate gains and supplemental payment programs, while noting moderating top-line g…
Volkswagen intends to increase exports of cars manufactured in China to markets outside Europe, focusing on South-East Asia, the Middle East and South America. Company leaders say China-made models benefit from lower costs, but Volkswagen faces ongoing pressure in its domestic China business amid intense competition and the need for further cost re…
Ro, the telehealth provider, reported a surge in new users seeking the recently introduced Wegovy pill for weight loss, including men who had avoided the injectable form. Company CEO Zach Reitano attributed the uptick to the pill's convenience and an introductory price point. Ro is also preparing a high-profile Super Bowl commercial and a broader h…
President Donald Trump publicly criticized Minneapolis Mayor Jacob Frey after the mayor declined to alter the city’s immigration enforcement stance in return for the removal of federal agents. The dispute follows a controversial federal deployment led by Tom Homan, which city officials say has harmed local communities and which escalated after fede…
Progressive posted a 25% increase in fourth-quarter profit, supported by higher personal auto policy volumes and an 8% rise in net premiums written. The insurer also said long-serving Chief Financial Officer John Sauerland will retire this summer, with Chief Strategy Officer Andrew Quigg slated to succeed him after a transition period. The company …
Snap Inc. said Wednesday it has formed a separate subsidiary, Specs Inc., to oversee the development and launch of its consumer augmented reality (AR) glasses. The announcement, which highlighted plans for an independent operating structure and possible outside investment, coincided with a roughly 4% rise in Snap shares. The company said the move i…
Snap is establishing a standalone division called Specs for its augmented reality smart glasses, opening the unit to minority investment and hiring nearly 100 global roles as it advances toward product launch. The move comes amid growing interest in smart eyewear led by Meta's Ray-Ban offerings, and follows industry warnings that success will hinge…
Spotify announced that it paid out more than $11 billion to the music industry in 2025, marking the largest annual payment from a retailer on record. Payouts increased by over 10% from the prior year, with independent artists and labels accounting for 50% of royalties. The company highlighted its payout formula and said it is reinvesting retained r…
Spotify disclosed that it paid out more than $11 billion to the music industry in 2025, the largest annual payment from a retailer to the music business on record. Payouts rose by over 10% versus 2024, with independent artists and labels receiving half of all royalties. The company says it returns roughly two-thirds of music revenue to rights holde…
Bernstein raised its 12-month price target for Sysco to $90 from $83 while keeping a Market Perform rating, citing better-than-expected U.S. local case volume growth and strengthened international sales. The move follows Sysco beating Q2 fiscal 2026 EPS and revenue forecasts and comes amid mixed analyst responses from UBS and Piper Sandler.
Bernstein SocGen Group has reaffirmed an Outperform rating on Meta Platforms Inc., keeping a $870 price target that implies roughly 30% upside from the current share price. The firm highlights Meta's robust gross margins and financial standing as underwriting continued investment in artificial intelligence, even as the company appears less visible …
Insider disclosures filed late this month reveal sizable stock purchases at Mirum Pharmaceuticals, Hycroft Mining and Intel, while senior executives at Goldman Sachs, AutoZone, Northern Trust and Wayfair reported multimillion-dollar sales. The filings span transactions executed between January 23 and January 26, 2026, and include option exercises, …
Bernstein SocGen Group trimmed its price target on Charter Communications to $220 from $240 while retaining a Market Perform rating, citing mounting uncertainty and an intensely competitive broadband market into 2026. Charter shares trade near their 52-week low, and the company recently completed $3 billion of senior unsecured notes to support refi…
Orion Group Holdings (ORN) has quietly moved into a better financial posture, with low leverage and solid liquidity, just as contract awards continue to stack up. The stock is trending above key moving averages with bullish MACD momentum, setting up a mid-term breakout retest trade. This is a long trade idea with defined entry, stop, and target lev…
F.N.B. Corp. is trading like a plain-vanilla regional bank, but the business mix (banking plus wealth and insurance) and its footprint across seven states and D.C. give it more ways to win as the rate cycle evolves. With shares near $17.39, FNB sits below its recent $18.30 high while valued at roughly 0.92x book and about 11-12x earnings. This trad…
Altimmune Inc. disclosed a $75 million registered direct offering of common stock to a new institutional investor, a move that coincided with a roughly 6.2% decline in premarket trading. Proceeds are earmarked to support preparation for a Phase 3 trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH) and for general corpora…
Roche’s CT-388 obesity data is good enough to matter and, more importantly, good enough to keep investors paying attention as Phase 3 ramps. But the stock is pressing fresh 52-week highs with an overbought RSI, which makes the risk-reward poor if you chase. The trade: wait for a pullback toward moving-average support, then look for a swing entry wi…
Barclays strategists say investors are demanding a larger premium to hold dollar-denominated assets following comments from President Donald Trump that appeared to favor a weaker dollar. The bank points to a growing divergence between U.S. rate expectations and EUR/USD, with traders continuing to sell the dollar ahead of a Federal Reserve decision …
GRI Bio Inc reported additional RNA-sequencing evidence from its Phase 2a trial of GRI-0621 in idiopathic pulmonary fibrosis (IPF) showing significant changes in genes tied to lung injury, myofibroblast activation, and fibrosis progression versus placebo. The company says the pattern of gene expression supports mechanisms consistent with fibrosis r…
